#ASCAT2024 | Michael Debaun kicked off the meeting earlier by discussing the molecular and cellular mechanisms of #SickleCellDisease, using examples from the CNS. #Hematology Academy for Sickle Cell & Thalassaemia (ASCAT)

#ASCAT2024 just started and I am looking forward to the next couple of days! Academy for Sickle Cell & Thalassaemia (ASCAT)

Thank you VJHemOnc for the highlight! Institut Imagine

Gala Dinner at ASCAT will be devoted to support Sickle Cell Fund at American University of Beirut Medical Center and the Chronic Care Center taking care of children with Thalassemia. Couldn’t be prouder of the efforts that went into achieving this. Miguel Abboud Ali Taher Academy for Sickle Cell & Thalassaemia (ASCAT)

Happening now: Basic Science session at ASCAT 2024 chaired by Sara El Hoss! Academy for Sickle Cell & Thalassaemia (ASCAT) Sara Morishige

📣 #MeetTheEditor Episode 2! We're excited to introduce you to our #AssociateEditor Peter Hokland. Stay tuned! #BrJHaem #Haematology @wileyOnc_Hem BSH - Haematology PETER HOKLAND

Our paper on reduced GATA1 levels and ineffective erythropoiesis in sickle cell anemia is out in Haematologica! Congratulations to Sara El Hoss for a fantastic job and all authors for their contributions! To be continued! School of Cancer & Pharmaceutical Sciences KHP Haematology haematologica.org/article/view/1…

Discussing "Ex Vivo Genetic Modification and Hematopoietic Cell Transplantation" at the ASH Scientific Workshop on Genomic Toxicities of Gene and Cell Therapies ASH

So happy to be at #ASH24 ASH ! Day 1 has been a blast with so many interesting talks and so many catch ups with friends and collaborators

Investigating erythropoiesis in VEXAS disease presented by Professor Hermine at #ASH24 @HermineLab1163 ASH

Happening now at #ASH24 our social media editor Sara El Hoss interviewing our newly appointed editor in chief Andrew M. Evens, DO, MBA, MSc ! Stay tuned to hear about Dr Evens vision for the journal Wiley Oncology & Hematology BSH - Haematology Rutgers Cancer Institute RWJBarnabas

Our interview in portuguese to our newly appointed editor in chief Dr Phillip Scheinberg at #ASH24! Stay tuned! Phillip Scheinberg @ElHoss_sara Giulia Scorrano

My favorite cell, the red cell, is being honored this year at #ASH24 ! ASH Thank you to Dr Narla for this amazing #ASH24

Andrew Evens (Andrew M. Evens, DO, MBA, MSc) named editor-in-chief of the British Journal of Haematology (British Journal of Haematology); Phillip Scheinberg (Phillip Scheinberg) named editor-in-chief of eJHaem Journal. cancerletter.com/in-brief/20241…

We are honored to introduce Belinda Avalos, MD (Belinda Avalos, MD) as the 2025 ASH President! A heartfelt thank you to Dr. Narla (Dr. Mohan Narla) for your incredible leadership this past year. #ASH24 #hematology

Very proud to be part of the @HermineLab1163 and to have our work highlighted in the presidential symposium of #ASH24 ASH Institut Imagine

Extremely proud of having my work presented as part of #ASH24 presidential symposium presented by Professor Hermine @HermineLab1163 ASH

📣 #ESHERYTHRO2025 READ THE FINAL PROGRAMME & REGISTER NOW ➡ bit.ly/3Qu3Ils 4th Translational Research Conference Pathophysiology & Clinical Advances in Sickle Cell Disease & Thalassemia 🗓️ March 14-16, Malahide (Dublin), Ireland 🇮🇪 #ESHCONFERENCES

At #EHA, we are thrilled to kick off the 2025 EHA-ASH Translational Research Training in Hematology (TRTH) spring Course! This immersive program brings together early-career researchers from around the world for a year-long journey of mentorship, collaboration, and skill-building

#ESHERYTHRO2025 started this morning! We are on for a great 2,5-day conference in Malahide! More information ➡ bit.ly/3Qu3Ils Chairs: Nica Cappellini, Michaela Fontenay Alexis Thompson #ESHCONFERENCES #SickleCell #Thalassemia #HAEMATOLOGY #HEMATOLOGY #MDSsm